Admenta 5 mg

Admenta 5 mg is a prescription treatment for patients with moderate to severe Alzheimer’s disease. Treatment should be started and supervised by a health care expert experienced in treating Alzheimer’s dementia. Close monitoring is required with the intake of this medicinal product. Each film-coated contains 5 mg of memantine hydrochloride, which belongs to the class known as anti-dementia medicines. Memory loss in this condition is due to a disturbance of message signals in the brain. The brain contains N-methyl D-aspartate (NMDA receptors) that are transmitting nerve signals plays an important role in learning and memory. Memantine is an NMDA receptor antagonist and works on these NMDA receptors, improving nerve signals and memory transmission.

You should tell your doctor straight away if you have recently changed or intend to change your diet or if you are suffering from renal tubular acidosis or severe urinary tract infections, as your doctor may need to adjust the dose of the medicine. Speak to your doctor for identifying the correct dosage of Admenta for adults and older adults. If you have suffered from impaired kidney function, your doctor will decide on a dose that suits best you. In this case, close monitoring of your kidney function should be performed by your doctor at specific intervals. The drug should be administered orally once daily. To benefits from the drug, use it regularly; swallow the tablet with some water. You can take the tablet before or after consuming food. Continue to take the pill as long as your doctor has prescribed you or is of benefit to you. Your doctor should assess your condition regularly. Your doctor will tell you whether your health condition allows you to drive or to use machines safely.

Admenta 5 mg should not be used in patients with hypersensitivity to the active substance or any other medicine ingredients. Caution is recommended in patients with epilepsy, history of convulsions, or patients with predisposing factors for epilepsy. Concomitant use of certain drugs such as ketamine, amantadine, or dextromethorphan should be avoided to avoid drug interaction. The mechanism of action suggests that the effects of dopaminergic agonists and anticholinergics may be enhanced by concomitant treatment with memantine. Concomitant use of memantine and amantadine should be avoided as it may increase the risk of pharmaco-toxic psychosis. Other pharmaceutical agents, including ranitidine, quinidine, procainamide, quinine, cimetidine, and nicotine, may also possibly interact with Admenta 5 mg. There may be a possibility of a low level of hydrochlorothiazide when memantine is coadministered with hydrochlorothiazide. Pregnant and breastfeeding women should discuss the risk and benefits of taking medicine.

Common side effects of Admenta 5 mg include drug sensitivity, drowsiness, hypertension, constipation, dizziness, balance disorder, headache, elevated liver function test, and dyspnoea. Other uncommon side effects of the medicine are pancreatitis, fatigue, vomiting, venous thrombosis, psychotic reaction, fungal infections, confusion, hallucinations, cardiac failure, and fungal infections.